Global Bioresorbable Implants Market Research Report 2022

Conventional implants were used by orthopedic surgeons previously to fix internal fixation for years. These implants have required a lot of development over the decades. Regardless it’s wide spread use, there are some problems associated with conventional implants which include the potential for long term relocation, stress shielding, breakage, reaction of the material, interference with the imaging devices and restricted growth in young patients. Recently, many bioresorbable implants have been made available as a feasible alternative to various indications. These bioresorbable implants dissolve in the human body and then get replaced by the natural bones. The implants which are somewhat large, interconnecting porous assembly is needed so that it can be integrated with the implant for better vascularization. By the additive manufacturing technology, this interconnecting porous structure can be manufactured directly. 
Due to the COVID-19 pandemic, the global Bioresorbable Implants market size is estimated to be worth US$ 5339 million in 2021 and is forecast to a readjusted size of US$ 7425.8 million by 2028 with a CAGR of 4.4% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Bioresorbable Implants market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Bioresorbable Implants landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
There are many factors which are driving the bioresorbable implants market like increasing incidences of chronic diseases, rising geriatric population, increasing incidences of road accidents growing disposable incomes and high level of healthcare. Additionally, the applications are increasing in medical and dental streams which are boosting the bioresorbable implants market.One of the most restraining factors of bioresorbable polymers is their inherent low strength compared to metals. Major tissue reactions have been reported in some cases. However, the time consuming approval processes of bioresorbable implants by the regulatory authorities, the reimbursement and the high cost of treatment will affect the bioresorbable implants market negatively. 
This report focuses on Bioresorbable Implants volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Bioresorbable Implants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Bioresorbable Implants Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Metals
Polymers
Segment by Application
Stents
Orthopedics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bioretec
DePuy Synthes
Stryker
Smith & Nephew
Biomet
Medtronic

Frequently Asked Questions